Navigation Links
StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.

ProductsStemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item StemSep CD45RA Tetramer, 100 uL
Price 
Description When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
2. StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
3. StemSep anti-Hu TCR alpha beta, 200 uL from StemCell Technologies, Inc.
4. StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
5. StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
6. StemSep Rat CD4+ T Cells, 10 mL from StemCell Technologies, Inc.
7. StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
8. StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
9. StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
10. StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.
11. Anti-human CD41 Tetramer, 200 uL from StemCell Technologies, Inc.
Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...
... recombinant IFNA2. Immunogen: Human IFNA2 ... in E. coli. The biological activity was ... OMIM: 147562, GeneID: ... MA Code: ABV0P9DPB ...
... longer need to perform time consuming and inaccurate ... Surveyor, any found variants of the sample when ... in our mutation electropherogram as a sharp peak. ... analysis mode is over 99%, with sensitivity to ...
...
Biology Products:
(Date:5/21/2015)... -- The Sync Project™ , a global collaboration ... announced a collaborative partnership with Berklee,s Institute for ... collaboration on original research, joint course development and an ... The Sync Project and BerkleeICE are exploring the launch ... 2015-2016 academic year.  The course will ...
(Date:5/20/2015)... May 20, 2015 NXT-ID, Inc. (NASDAQ: ... wholly owned subsidiary, 3D-ID LLC, a company engaged in ... for the biometrics technology portion of the recently awarded ... the Department of the Army. 3D-ID LLC ... for government, law enforcement and security agencies. ...
(Date:5/19/2015)...  Technology is rapidly advancing, outpacing enterprises, ability to ... Passwords and their management are soon to be rendered ... such as those developed by the FIDO Alliance™. With ... for BYOD, COPE, IoT, and mobile payments, the interconnected ... In response to the call for seamless, ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... pollution and heavy fishingare adding insult to injury in ... by the Wildlife Conservation Society and the University of ... found that pollution and overfishing on reef systems have ... wormsthat further degrade corals, a discovery that underlines the ...
... at UCLA,s Jonsson Cancer Center found that the children ... having retinoblastoma, a malignant tumor of the retina which ... which focused on babies born in California, also found ... for retinoblastoma, as were children born to women with ...
... are overweight or obese can encounter a host of health ... children grow and develop, at least initially. In a ... a team led by a University of Iowa researcher compared ... obese mothers with those born to normal-weight mothers. ...
Cached Biology News:Microbes, sponges, and worms add to coral reef woes 2Microbes, sponges, and worms add to coral reef woes 3US-born Latinas at great risk of having babies with retinoblastoma 2Infants of overweight mothers grow more slowly 2Infants of overweight mothers grow more slowly 3
(Date:5/27/2015)... , May 27, 2015  CytomX, a biotechnology ... cancer, today announced the appointments of Bob ... Cynthia Ladd as senior vice president and ... chief financial officer of Onyx Pharmaceuticals, an Amgen ... consultant and legal counsel to several leading biotech ...
(Date:5/27/2015)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ), ... innovative therapies primarily in the areas of dermatology ... of the Company,s Series A and Series A-1 ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO At March 31, ... Series A Preferred Stock and Series A-1 Preferred ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 WORMS, ... Grace & Co. (NYSE: GRA) announces that its ... manufacturing practice (GMP) certification from EXCiPACTâ„¢, an independent ... pharmaceutical excipients. , All three Grace ... pharmaceutical grade excipient silica gels have now received ...
(Date:5/26/2015)... , May 26, 2015   Intrexon Corporation (NYSE: ... that Gregory Frost , Ph.D., Senior Vice President and ... 2015 Global Healthcare Conference on Wednesday, June 3 rd , ... New York City . About ... is Powering the Bioindustrial Revolution with Better DNA ™ ...
Breaking Biology Technology:CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2